Silphium Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Silphium Asset Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200,000	Closed	-$13.6M	–	58
2022 Q3	$13.6M	Buy	+200,000	New	+$11M	12.25%	1

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Silphium Asset Management's GBT Position: Q4 2022 in Review

Silphium Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 200,000 shares — an estimated $13.6M sold.

Silphium Asset Management first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $13.6M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Silphium Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Silphium Asset Management sold 200,000 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $13.6M.
Silphium Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Silphium Asset Management's Global Blood Therapeutics, Inc. position peaked at $13.6M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Silphium Asset Management's 13F filing for Q4 2022, filed 30 Jan 2025.